Adrenergic Antagonists
Adrenergic Antagonists is a class of pharmacological agents that belong to the broader category of autonomic receptor-blocking drugs, distinguished by their specific ability to inhibit adrenergic receptors activated by catecholamines such as norepinephrine and epinephrine, thereby attenuating sympathetic nervous system signaling.
4.5K
Publications
193.8K
Citations
13.4K
Authors
2.1K
Institutions
Publications per year
2017–2026
96
Variants
Adrenergic BlockersAdrenoceptor AntagonistsAdrenoceptor Blockers
Parents
4.5K
John D. McConnell, Claus G. Roehrborn, Oliver Bautista et al. · New England Journal of Medicine · 2003 · 2K citations · Full text
1–5 of 4.5K
13.4K
29
h-index
17
h-index
15
h-index
14
h-index
14
h-index
1–5 of 13.4K
2.1K
Duke Medical Center
Durham, United States
36 h-index
184 publications
19.5K citations
Duke University Hospital
Durham, United States
32 h-index
118 publications
15K citations
University of California, San Francisco
San Francisco, United States
28 h-index
120 publications
14K citations

The University of Melbourne
Melbourne, Australia
25 h-index
123 publications
4.2K citations
Inserm
Paris, France
25 h-index
185 publications
7.9K citations
National Institutes of Health
Bethesda, United States
24 h-index
84 publications
6.7K citations
Stanford University
Stanford, United States
24 h-index
125 publications
7.5K citations

Howard Hughes Medical Institute
Chevy Chase, United States
23 h-index
96 publications
12.1K citations
1–8 of 2.1K
BJP · 318 publications · 16K citations
63
h-index
318 publications · 12.5K citations
58
h-index
Repository · 363 publications · 12.1K citations
52
h-index
70 publications · 6.2K citations
41
h-index
JBC · 50 publications · 5.7K citations
40
h-index
1–5